Literature DB >> 2031836

Long term observations in a patient with pseudohypoaldosteronism.

R J Hogg1, J F Marks, D Marver, J C Frolich.   

Abstract

This paper describes a patient with severe pseudohypoaldosteronism (PHA) for over 12 years. The patient presented at 10 days of age with a serum sodium of 118 mEq/l and potassium of 12 mEq/l. After failing to maintain normal fluid and electrolyte status with standard therapy, including maximal mineralocorticoid stimulation, he was given a special formula containing minimal potassium plus salt supplements which normalized his electrolyte status. However, when he was 4.5 years of age, an acute gastrointestinal illness led to severe volume depletion, hyperkalemia, and cardiopulmonary arrest. This resulted in significant neurological impairment. At 12.5 years of age, the patient continues to require massive sodium supplements and his diet contains less than 0.5 mEq/kg potassium daily; his height and weight are at the 95th percentile, thus demonstrating that normal growth may be achieved with strict dietary manipulation in a patient with persistent, severe PHA. Serial studies to further define the lesion in this patient have demonstrated: (1) normal binding of aldosterone to aldosterone binding globulin (5.1% bound); (2) normal mineralocorticoid "activity"; (2) suppressible renin and aldosterone levels; (4) increased prostaglandin excretion (3.15 micrograms/g creatinine); (5) lack of benefit of prostaglandin inhibition with indomethacin; (6) normal proximal tubule function (CNa + CH2O = 18.0 ml/100 ml glomerular filtration rate; (7) impaired distal tubule function (CH2O/CNa + CH2O = 79.8%) during water diuresis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2031836     DOI: 10.1007/bf01095953

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  Tubular Na, K-ATPase deficiency, the cause of the congenital renal salt-losing syndrome.

Authors:  J R Bierich; U Schmidt
Journal:  Eur J Pediatr       Date:  1976-01-02       Impact factor: 3.183

2.  A salt-losing syndrome in infancy. Pseudo-hypoadrenocorticalism.

Authors:  D N RAINE; J ROY
Journal:  Arch Dis Child       Date:  1962-10       Impact factor: 3.791

3.  Pseudohypoaldosteronism.

Authors:  W Proesmans; H Geussens; L Corbeel; R Eeckels
Journal:  Am J Dis Child       Date:  1973-10

4.  Pseudohypoaldosteronism: severe salt wasting in infancy caused by generalized mineralocorticoid unresponsiveness.

Authors:  M O Savage; I G Jefferson; M J Dillon; P J Milla; J W Honour; D B Grant
Journal:  J Pediatr       Date:  1982-08       Impact factor: 4.406

5.  Pseudohypoaldosteronism. Clinical, biochemical and morphological studies in a long-term follow-up.

Authors:  S Petersen; J Giese; A M Kappelgaard; H T Lund; J O Lund; M D Nielsen; A C Thomsen
Journal:  Acta Paediatr Scand       Date:  1978-03

6.  Congenital pseudohypoaldosteronism: case report and review. Effect of indomethacin during sodium chloride depletion.

Authors:  S Rampini; J Furrer; H P Keller; H Bucher; M Zachmann
Journal:  Helv Paediatr Acta       Date:  1978-06

7.  Urinary prostaglandins. Identification and origin.

Authors:  J C Frölich; T W Wilson; B J Sweetman; M Smigel; A S Nies; K Carr; J T Watson; J A Oates
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

8.  Aldosterone-receptor deficiency in pseudohypoaldosteronism.

Authors:  D Armanini; U Kuhnle; T Strasser; H Dorr; I Butenandt; P C Weber; J R Stockigt; P Pearce; J W Funder
Journal:  N Engl J Med       Date:  1985-11-07       Impact factor: 91.245

9.  Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients.

Authors:  A Sebastian; J M Sutton; H N Hulter; M Schambelan; S M Poler
Journal:  Kidney Int       Date:  1980-12       Impact factor: 10.612

10.  [Familial pseudohypoaldosteronism (apropos of 5 cases)].

Authors:  C Roy
Journal:  Arch Fr Pediatr       Date:  1977-01
View more
  4 in total

1.  Functional expression of a pseudohypoaldosteronism type I mutated epithelial Na+ channel lacking the pore-forming region of its alpha subunit.

Authors:  O Bonny; A Chraibi; J Loffing; N F Jaeger; S Gründer; J D Horisberger; B C Rossier
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Glucocorticoid and mineralocorticoid resistance.

Authors:  P A Komesaroff; M C Zennaro
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 3.  Epithelial sodium channel (ENaC) family: Phylogeny, structure-function, tissue distribution, and associated inherited diseases.

Authors:  Israel Hanukoglu; Aaron Hanukoglu
Journal:  Gene       Date:  2016-01-07       Impact factor: 3.688

4.  Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.

Authors:  Nasifa Nur; Cameron Lang; Juanita K Hodax; Jose Bernardo Quintos
Journal:  Case Rep Pediatr       Date:  2017-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.